Here is a comprehensive review of acute and chronic pharyngitis integrating content from Cummings Otolaryngology, Goldman-Cecil Medicine, and other authoritative sources.
Pharyngitis: Acute and Chronic
1. Definition and Classification
Pharyngitis is inflammation of the mucosa and underlying structures of the pharynx. It is broadly classified by:
By Duration:
- Acute pharyngitis — onset over hours to days; resolves within 3–7 days (infectious majority)
- Chronic pharyngitis — persistent or recurrent inflammation lasting weeks to months; often non-infectious in etiology
Chronic pharyngitis is further classified morphologically into three forms:
| Form | Key Feature |
|---|
| Hypertrophic (granular) | Lymphoid hyperplasia; granular cobblestone posterior wall |
| Atrophic (sicca) | Mucosal thinning, dryness, crusting; glandular atrophy |
| Simple (catarrhal) | Mild persistent mucosal congestion without structural change |
(Some classifications treat hypertrophic and granular as synonyms; others distinguish a lateral hypertrophic variant — hyperplasia of lateral bands — as a separate subtype.)
2. Etiology
Acute Pharyngitis
Viral (majority — ~70–90% of acute cases):
- Rhinovirus, influenza A/B, parainfluenza, adenovirus, coxsackievirus (herpangina, hand-foot-and-mouth), echovirus, RSV
- Epstein-Barr virus (EBV) — infectious mononucleosis
- Herpes simplex virus (HSV) — exudative or non-exudative pharyngitis
- HIV (acute retroviral syndrome)
- Rarely: CMV, measles, rubella
Bacterial (10–30% of cases; more common in children):
- Streptococcus pyogenes (Group A β-hemolytic Streptococcus, GAS) — most important bacterial cause (20–40% of pediatric cases; 5–15% of adult cases)
- Non-group A β-hemolytic streptococci (Groups B, C, G)
- Neisseria gonorrhoeae — sexually transmitted; often overlooked
- Corynebacterium diphtheriae — membranous pharyngitis; rare in vaccinated populations
- Arcanobacterium haemolyticum — resembles streptococcal pharyngitis with rash in young adults
- Fusobacterium necrophorum — Lemierre syndrome risk
- Mycoplasma pneumoniae, Chlamydophila pneumoniae — atypical organisms
Other:
- Fungal (Candida albicans) — immunosuppressed patients
- Parasitic (rare)
Chronic Pharyngitis
- Persistent low-grade infection or recurrent acute episodes
- Laryngopharyngeal reflux (LPR) — a leading non-infectious cause
- Tobacco smoke, alcohol, dry air, occupational irritants, dust
- Chronic mouth breathing (nasal obstruction, deviated septum, adenoid hypertrophy)
- Chronic sinusitis with postnasal drip
- Allergy / vasomotor rhinitis
- Systemic diseases: Sjögren syndrome, sarcoidosis, amyloidosis, pemphigus
- Vitamin A deficiency (contributes to atrophic changes)
3. Pathogenesis
Acute
- Viral: Direct cytopathic effect on pharyngeal epithelium → mucosal edema, erythema, cellular infiltrate. Many viral infections are transmitted droplet or contact route.
- GAS (Streptococcal): S. pyogenes adheres to pharyngeal epithelium via M protein and other surface adhesins → local invasion → release of streptolysin O, streptolysin S, pyrogenic exotoxins (causing scarlet fever rash), DNase, hyaluronidase → intense local inflammatory response → fever, exudate, lymphadenopathy.
- Pharyngitis induces antibodies against M protein, streptolysin O, DNase, hyaluronidase, and pyrogenic exotoxins.
- Non-treated infection may spread suppuratively or trigger immune-mediated sequelae (rheumatic fever, glomerulonephritis).
Chronic
- Repeated acute insults → chronic mucosal edema → lymphoid hyperplasia (hypertrophic/granular form)
- Prolonged irritation (smoke, reflux, dry air) → progressive glandular atrophy, mucosal thinning, decreased mucus secretion → atrophic form
- LPR: Acid and pepsin reach the posterior pharynx → posterior laryngitis, interarytenoid edema, erythematous arytenoids, reactive changes
4. Clinical Symptoms
Acute Pharyngitis
| Feature | Viral | GAS Bacterial |
|---|
| Onset | Gradual | Abrupt |
| Sore throat severity | Mild–moderate | Moderate–severe |
| Fever | Low-grade or absent | High (38.5–40°C) |
| Cough/rhinorrhea | Common | Absent (key negative predictor) |
| Hoarseness | Sometimes | Rare |
| Headache | Occasional | Common |
| Malaise | Common | Common |
| Nausea/vomiting | Rare | Common (children) |
Additional presentations:
- EBV mononucleosis: fever, severe malaise, pharyngitis, cervical lymphadenopathy (large and tender), splenomegaly, palatal petechiae, occasional green/gray tonsillar exudate (indistinguishable from GAS)
- Herpangina (Coxsackievirus): vesicles → ulcers on anterior tonsillar pillars, soft palate, posterior pharynx
- Influenza: abrupt fever, headache, myalgias, sore throat, mild pharyngeal hyperemia without exudate
- HIV acute retroviral: fever, diffuse lymphadenopathy, maculopapular rash, pharyngitis (often with ulcerations)
Chronic Pharyngitis
All forms share:
- Persistent throat discomfort, tickling, irritation, or dryness
- Chronic throat-clearing
- Low-grade dysphagia
- Postnasal drip sensation ("globus")
5. Physical Examination & Diagnostics
Acute Pharyngitis — Oropharyngeal Findings
Acute exudative streptococcal pharyngitis: erythematous, hypertrophied tonsils with confluent white-yellow exudate. — Goldman-Cecil Medicine
Clinical scoring — Modified Centor Score (McIsaac Score):
| Criterion | Points |
|---|
| Temperature > 38°C | +1 |
| Absence of cough | +1 |
| Tender anterior cervical adenopathy | +1 |
| Tonsillar swelling or exudate | +1 |
| Age 3–14 years | +1 |
| Age ≥ 45 years | −1 |
- Score 0–1: No testing or antibiotics needed
- Score 2–3: Rapid antigen test recommended
- Score ≥ 4: Empiric antibiotics reasonable; culture if rapid test negative
Laboratory diagnostics:
- Rapid antigen detection test (RADT): Sensitivity ~85%; specificity high. If negative in children/adolescents → send throat culture.
- Rapid nucleic acid test (NAAT): Sensitivity 97.5%, specificity 95% — preferred.
- Throat culture: Gold standard. Posterior pharynx/tonsillar surface swab. Treat if positive; no need to culture adults with negative rapid test (low GAS prevalence, low rheumatic fever risk).
- Monospot/heterophile antibody test: EBV mononucleosis screening
- CBC: Atypical lymphocytosis in EBV; leukocytosis in bacterial infection
- ASO titer, anti-DNase B: Retrospective confirmation of GAS infection (used for rheumatic fever / glomerulonephritis workup)
6. Differential Diagnosis: Chronic Pharyngitis Forms
This is the core morphological/clinical distinction:
| Feature | Hypertrophic (Granular) | Atrophic (Sicca) |
|---|
| Pathology | Lymphoid follicle hyperplasia; submucosal edema; mucus gland hypertrophy | Mucosal thinning; glandular atrophy; submucosal fibrosis; reduced mucus secretion |
| Pharyngeal wall appearance | Cobblestone / granular posterior wall; irregular nodules of lymphoid tissue; hyperemic, thickened mucosa; increased mucus secretion (may be thick, sticky) | Pale, dry, thin, shiny mucosa; may have dry crusts or adherent mucus; vascular pattern visible through atrophic mucosa |
| Tonsils / lateral bands | Enlarged; lateral bands may be thickened (lateral hypertrophic variant) | Absent or regressed; mucosa may bridge former tonsillar fossa |
| Secretions | Excessive, thick, sticky mucus — causes hawking/throat-clearing | Scanty, viscous; dry crusts (especially posterior wall); patients complain of "sticky throat" |
| Symptoms | Sensation of something in throat (globus), hawking, postnasal drip, cough reflex, mild sore throat | Burning, dryness, scratching sensation, halitosis from crusts, dysphagia |
| Associated conditions | Chronic sinusitis, adenoid hypertrophy, chronic mouth-breathing, GER, tobacco | Sjögren syndrome, advancing age, heavy smoking (paradoxically), vitamin deficiency, post-radiation, prolonged mouth-breathing in dry climates |
| Etiology emphasis | Repeated infections, LPR, allergic/chronic mucosal irritation | Long-standing irritation, autoimmune glandular destruction, post-atrophic rhinitis |
Key differentiator: The posterior pharyngeal wall appearance is the cornerstone — cobblestone granularity (hypertrophic) vs. pale, dry, smooth atrophic mucosa.
7. Treatment
Acute Pharyngitis
Viral:
- Supportive: analgesics (NSAIDs, acetaminophen), adequate hydration, throat lozenges, warm saline gargles
- Influenza: Neuraminidase inhibitors (oseltamivir 75 mg bid × 5 days, zanamivir) — effective only if started within 48 hours; reduces duration by 1–2.5 days; recommended in high-risk groups
- EBV mononucleosis: Supportive; avoid contact sports (splenomegaly/rupture risk); avoid amoxicillin/ampicillin (causes widespread maculopapular rash in ~90% of EBV patients); corticosteroids for severe airway edema or thrombocytopenia
- HSV: Acyclovir — especially in immunosuppressed patients with chronic herpetic pharyngitis
GAS Bacterial Pharyngitis:
First-line:
- Penicillin V 250 mg × 4/day or 500 mg × 2/day × 10 days (antibiotic of choice)
- Amoxicillin 500 mg × 3/day or 875 mg × 2/day × 10 days (often preferred in children — pleasant taste, once-daily dosing studied)
Penicillin-allergic:
- Azithromycin 500 mg/day × 3 days (Z-pack) — note increasing macrolide resistance
- Clindamycin 300 mg × 4/day × 10 days
Recurrent infection (β-lactamase-producing co-pathogens):
- Amoxicillin-clavulanate 875/125 mg × 2/day × 10 days
- Cefuroxime axetil 250 mg × 2/day × 10 days — more effective than penicillin for primary treatment; effective for persistent infection
Adjunct:
- Single-dose oral or IM corticosteroid (dexamethasone 10 mg PO/IM × 1) reduces severity and duration of pain — particularly in severe cases and children
- Antibiotics reduce contagion period from ~2 weeks to 24 hours after initiation
- Must begin antibiotics within 10 days of symptom onset to prevent rheumatic fever
- Antibiotics do NOT reduce risk of post-streptococcal glomerulonephritis
Gonococcal pharyngitis:
- Ceftriaxone 500 mg IM single dose (+ treat for Chlamydia if not tested)
Candidal pharyngitis:
- Fluconazole or nystatin suspension
Chronic Pharyngitis — General Principles
- Eliminate causative factors: smoking cessation, alcohol reduction, humidification, treat nasal obstruction, sinusitis, adenoids
- Treat LPR: dietary modification, elevate head of bed, proton pump inhibitor × 3 months
- Treat allergic disease: antihistamines, intranasal corticosteroids
Chronic Hypertrophic (Granular) Pharyngitis
- Address underlying causes (reflux, allergy, chronic infection)
- Alkaline or saline irrigations/gargles (reduce crusts, thin secretions)
- Topical anti-inflammatory sprays
- Cauterization or laser ablation of discrete granular nodules (in refractory cases)
- Immunotherapy for allergic component
Chronic Atrophic Pharyngitis
- Mucosal hydration: frequent water intake, saline irrigations, humidification
- Vitamin A supplementation (addresses glandular atrophy in deficiency states)
- Alkaline-oil inhalations (olive oil, mineral oil aerosols — lubricate mucosa)
- Treat underlying systemic disease (Sjögren: artificial saliva, pilocarpine; sarcoid: corticosteroids)
- Biostimulants (FIBS, aloe vera — used in Eastern European protocols)
- Avoid further irritants absolutely
8. Complications
Acute Pharyngitis (especially GAS)
Suppurative complications:
- Peritonsillar abscess (quinsy) — most common local complication; unilateral uvular deviation, "hot potato" voice, trismus
- Retropharyngeal/parapharyngeal abscess — neck stiffness, drooling, airway risk
- Otitis media — spread via Eustachian tube
- Sinusitis — contiguous spread
- Mastoiditis, meningitis, brain abscess (rare)
- Lemierre syndrome (Fusobacterium): septic thrombophlebitis of internal jugular vein
- Bacteremia / septicemia
- Scarlet fever (GAS pyrogenic exotoxin): characteristic rash, strawberry tongue, perioral pallor
- Streptococcal toxic shock syndrome (uncommon)
Non-suppurative (immunological) complications — GAS only:
- Acute Rheumatic Fever (ARF): 2–4 weeks post-pharyngitis; carditis, migratory polyarthritis, Sydenham chorea, erythema marginatum, subcutaneous nodules — prevented by antibiotics within 10 days
- Post-streptococcal glomerulonephritis (PSGN): 1–3 weeks post-pharyngitis; hematuria, proteinuria, edema, hypertension — NOT prevented by antibiotics
EBV Mononucleosis:
- Splenic rupture (avoid contact sports for 3–4 weeks)
- Airway obstruction from massive tonsillar enlargement
- Hemolytic anemia, thrombocytopenia
- Meningoencephalitis (rare)
- Amoxicillin/ampicillin rash
Chronic Pharyngitis:
- Chronic cough, recurrent upper respiratory infections
- Progression to laryngitis, chronic laryngopharyngeal reflux disease
- Sleep-disordered breathing
- Risk marker for malignancy (persistent symptoms warrant laryngoscopy if >4 weeks duration without resolution)
9. Prevention
Acute (especially GAS):
- Hand hygiene — primary prevention of spread
- Avoid sharing utensils, glasses
- Respiratory droplet precautions
- Prompt antibiotic treatment shortens infectious period to 24 hours post-initiation
- Influenza vaccination annually — at least 70% effective; recommended for age >50, children 6–24 months, pregnant women, healthcare workers, immunocompromised, residents of long-term care facilities
- Hib vaccine — prevents epiglottitis (not pharyngitis per se, but related)
- Tonsillectomy — reduces frequency of throat infections in patients with recurrent symptomatic GAS episodes despite appropriate antimicrobial therapy (effective short-term)
Chronic:
- Smoking cessation
- Nasal breathing — treat all causes of obstruction
- Adequate indoor humidification (especially in dry/cold climates)
- Treat GERD/LPR proactively
- Occupational protection from dust and chemical irritants
- Avoid excessive voice strain
Sources:
- Cummings Otolaryngology Head and Neck Surgery (Chapters 201 and the pharyngitis/laryngitis review chapter)
- Goldman-Cecil Medicine, International Edition (Chapters 269 and 397)
- Tintinalli's Emergency Medicine; ROSEN's Emergency Medicine; Sherris & Ryan's Medical Microbiology